Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44


Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.

Deslouches B, Hasek ML, Craigo JK, Steckbeck JD, Montelaro RC.

J Med Microbiol. 2016 Jun;65(6):554-565. doi: 10.1099/jmm.0.000258. Epub 2016 Apr 5.


Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Craigo JK, Ezzelarab C, Cook SJ, Liu C, Horohov D, Issel CJ, Montelaro RC.

PLoS Pathog. 2015 Jan 8;11(1):e1004610. doi: 10.1371/journal.ppat.1004610. eCollection 2015 Jan.


Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.

Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Burns JL, Montelaro RC.

Antimicrob Agents Chemother. 2015 Feb;59(2):1329-33. doi: 10.1128/AAC.03937-14. Epub 2014 Nov 24.


Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.

Liu C, Cook SJ, Craigo JK, Cook FR, Issel CJ, Montelaro RC, Horohov DW.

Vet Immunol Immunopathol. 2014 Oct 15;161(3-4):161-9. doi: 10.1016/j.vetimm.2014.08.001. Epub 2014 Aug 10.


Differential sensitivity of Src-family kinases to activation by SH3 domain displacement.

Moroco JA, Craigo JK, Iacob RE, Wales TE, Engen JR, Smithgall TE.

PLoS One. 2014 Aug 21;9(8):e105629. doi: 10.1371/journal.pone.0105629. eCollection 2014.


Scavenger receptor function of mouse Fcγ receptor III contributes to progression of atherosclerosis in apolipoprotein E hyperlipidemic mice.

Zhu X, Ng HP, Lai YC, Craigo JK, Nagilla PS, Raghani P, Nagarajan S.

J Immunol. 2014 Sep 1;193(5):2483-95. doi: 10.4049/jimmunol.1303075. Epub 2014 Jul 18.


Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41.

Kuhlmann AS, Steckbeck JD, Sturgeon TJ, Craigo JK, Montelaro RC.

J Biol Chem. 2014 Mar 14;289(11):7630-40. doi: 10.1074/jbc.M113.529339. Epub 2014 Feb 4.


Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.

Craigo JK, Montelaro RC.

Viruses. 2013 Dec 2;5(12):2963-76. doi: 10.3390/v5122963. Review.


Envelope determinants of equine lentiviral vaccine protection.

Craigo JK, Ezzelarab C, Cook SJ, Chong L, Horohov D, Issel CJ, Montelaro RC.

PLoS One. 2013 Jun 13;8(6):e66093. doi: 10.1371/journal.pone.0066093. Print 2013.


Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.

Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Mietzner TA, Montelaro RC.

Antimicrob Agents Chemother. 2013 Jun;57(6):2511-21. doi: 10.1128/AAC.02218-12. Epub 2013 Mar 18.


Challenges and proposed solutions for more accurate serological diagnosis of equine infectious anaemia.

Issel CJ, Scicluna MT, Cook SJ, Cook RF, Caprioli A, Ricci I, Rosone F, Craigo JK, Montelaro RC, Autorino GL.

Vet Rec. 2013 Feb 23;172(8):210. doi: 10.1136/vr-2012-100735. Epub 2012 Nov 16.


Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus.

Carter DM, Bloom CE, Nascimento EJ, Marques ET, Craigo JK, Cherry JL, Lipman DJ, Ross TM.

J Virol. 2013 Feb;87(3):1400-10. doi: 10.1128/JVI.02257-12. Epub 2012 Oct 31.


Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.

Craigo JK, Ezzelarab C, Montelaro RC.

J Virol Methods. 2012 Nov;185(2):221-7. doi: 10.1016/j.jviromet.2012.07.007. Epub 2012 Jul 20.


The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies.

Liu C, Cook FR, Cook SJ, Craigo JK, Even DL, Issel CJ, Montelaro RC, Horohov DW.

Vet Immunol Immunopathol. 2012 Aug 15;148(3-4):302-10. doi: 10.1016/j.vetimm.2012.06.018. Epub 2012 Jun 23.


Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice.

Giles BM, Bissel SJ, Craigo JK, Dealmeida DR, Wiley CA, Tumpey TM, Ross TM.

J Virol. 2012 Feb;86(3):1500-13. doi: 10.1128/JVI.06034-11. Epub 2011 Nov 30.


Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication.

Steckbeck JD, Craigo JK, Barnes CO, Montelaro RC.

J Biol Chem. 2011 Aug 5;286(31):27156-66. doi: 10.1074/jbc.M111.258855. Epub 2011 Jun 9.



Craigo JK, Montelaro RC.

Future Virol. 2011 Feb;6(2):139-142. No abstract available.


Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment.

Qin S, Alcorn JF, Craigo JK, Tjoeng C, Tarwater PM, Kolls JK, Reinhart TA.

J Immunol. 2011 Mar 15;186(6):3693-700. doi: 10.4049/jimmunol.1002876. Epub 2011 Feb 9.


Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.

Craigo JK, Barnes S, Cook SJ, Issel CJ, Montelaro RC.

Vaccine. 2010 Nov 29;28(51):8095-104. doi: 10.1016/j.vaccine.2010.10.003. Epub 2010 Oct 16.


Animal lentiviruses. Editorial.

Craigo JK, Ross TM.

Curr HIV Res. 2010 Jan;8(1):1. No abstract available.


Genetic characterization of HIV-1 from semen and blood from clade C-infected subjects from India and effect of therapy in these body compartments.

Shen C, Ding M, Craigo JK, Tarwater P, Chatterjee R, Roy P, Guha SK, Saha B, Modak D, Neogi D, Chen Y, Gupta P.

Virology. 2010 Jun 5;401(2):190-6. doi: 10.1016/j.virol.2010.01.033. Epub 2010 Mar 15.


EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy.

Craigo JK, Montelaro RC.

Curr HIV Res. 2010 Jan;8(1):81-6. Review.


Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.

Faith SA, Wu Y, Kuhrt D, Steckbeck JD, Craigo JK, Clements JE, Cole KS.

Virology. 2010 Apr 25;400(1):86-92. doi: 10.1016/j.virol.2010.01.014. Epub 2010 Feb 11.


An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.

Craigo JK, Barnes S, Zhang B, Cook SJ, Howe L, Issel CJ, Montelaro RC.

Retrovirology. 2009 Oct 20;6:95. doi: 10.1186/1742-4690-6-95.


Characterization of an equine macrophage cell line: application to studies of EIAV infection.

Fidalgo-Carvalho I, Craigo JK, Barnes S, Costa-Ramos C, Montelaro RC.

Vet Microbiol. 2009 Apr 14;136(1-2):8-19. doi: 10.1016/j.vetmic.2008.10.010. Epub 2008 Nov 1.


Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.

Tagmyer TL, Craigo JK, Cook SJ, Even DL, Issel CJ, Montelaro RC.

J Virol. 2008 Apr;82(8):4052-63. doi: 10.1128/JVI.02028-07. Epub 2008 Jan 30.


Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Craigo JK, Zhang B, Barnes S, Tagmyer TL, Cook SJ, Issel CJ, Montelaro RC.

Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15105-10. Epub 2007 Sep 10.


Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.

Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC.

J Gen Virol. 2007 Apr;88(Pt 4):1324-36.


Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope.

Toapanta FR, Craigo JK, Montelaro RC, Ross TM.

Curr HIV Res. 2007 Mar;5(2):199-209.


Characterization of the gp120 of circulating HIV type 1 in a group of infected Chinese blood/plasma donors with asymptomatic and symptomatic stages of the disease.

Chen Y, Craigo JK, Ding M, Guo Y, Shen S, Zhou Y, Wu H, Gupta P.

AIDS Res Hum Retroviruses. 2006 Nov;22(11):1167-71.


Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.

Craigo JK, Durkin S, Sturgeon TJ, Tagmyer T, Cook SJ, Issel CJ, Montelaro RC.

Vaccine. 2007 Jan 15;25(5):834-45. Epub 2006 Sep 22.


HIV-1 in genital compartments: vexing viral reservoirs.

Craigo JK, Gupta P.

Curr Opin HIV AIDS. 2006 Mar;1(2):97-102. doi: 10.1097/01.COH.0000200507.27578.26.


Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin.

Rodriguez MA, Chen Y, Craigo JK, Chatterjee R, Ratner D, Tatsumi M, Roy P, Neogi D, Gupta P.

Virology. 2006 Feb 20;345(2):328-36. Epub 2005 Nov 9. Erratum in: Virology. 2010 Feb 5;397(1):242.


Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.

Craigo JK, Sturgeon TJ, Cook SJ, Issel CJ, Leroux C, Montelaro RC.

Virology. 2006 Jan 20;344(2):340-53. Epub 2005 Oct 13.


Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.

Deslouches B, Islam K, Craigo JK, Paranjape SM, Montelaro RC, Mietzner TA.

Antimicrob Agents Chemother. 2005 Aug;49(8):3208-16.


Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.

Craigo JK, Li F, Steckbeck JD, Durkin S, Howe L, Cook SJ, Issel C, Montelaro RC.

J Virol. 2005 Mar;79(5):2666-77.


Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy.

Craigo JK, Patterson BK, Paranjpe S, Kulka K, Ding M, Mellors J, Montelaro RC, Gupta P.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1196-209.


Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

Leroux C, Craigo JK, Issel CJ, Montelaro RC.

J Virol. 2001 May;75(10):4570-83.


Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.

Lichtenstein DL, Craigo JK, Leroux C, Rushlow KE, Cook RF, Cook SJ, Issel CJ, Montelaro RC.

Virology. 1999 Oct 25;263(2):408-17.

Supplemental Content

Loading ...
Support Center